Has Vinay Arya, MD received payments from drug or device companies?

Yes. Drug and device makers reported $448 in general payments to Vinay Arya, MD across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vinay Arya, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vinay Arya, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vinay Arya, MD

Psychiatry · Monroe Township, NJNPI 1376565127

Payments from drug & device makers

$448in general payments, 2019–2025

Across 14 payments — averaging $31.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$168
Teva Pharmaceuticals USA, Inc.$94
Alkermes, Inc.$58
E.r. Squibb & Sons, L.L.C.$34
Otsuka America Pharmaceutical, Inc.$32
AbbVie$32
plus $30 from 2 others

What the payments were for

Food & beverage$41793%
Education$317%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	3	$168
Teva Pharmaceuticals USA, Inc.	1	$94
Alkermes, Inc.	3	$58
E.r. Squibb & Sons, L.L.C.	1	$34
Otsuka America Pharmaceutical, Inc.	2	$32
AbbVie	2	$32
Takeda Pharmaceuticals U.S.A., Inc.	1	$15
Neurocrine Biosciences, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CAPLYTA$126

How this compares

$448 in reported general payments places this provider in the 60th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey →

Medicare billing

Part B allowed, 2024

$19,911

Medicare patients

Services billed

311

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	59	$135,035
Abilify MaintenaAripiprazole	37	$90,326
VraylarCariprazine Hcl	33	$50,599
RexultiBrexpiprazole	28	$41,564
AustedoDeutetrabenazine	14	$40,950
ClozarilClozapine	22	$40,365
Risperidone ErRisperidone Microspheres	15	$15,719
FetzimaLevomilnacipran Hcl	32	$15,522
Risperdal ConstaRisperidone Microspheres	13	$13,681
Clozapine	146	$7,003
Effexor XrVenlafaxine Hcl	11	$6,399
Olanzapine	118	$6,229
Aripiprazole	144	$6,148
Divalproex Sodium ErDivalproex Sodium	81	$4,530
Carbamazepine ErCarbamazepine	24	$3,487

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti	$32	$131,88965 claims
AbbVieVraylar, Fetzima	$32	$66,12165 claims
Teva Pharmaceuticals USA, Inc.Austedo	$94	$40,95014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Monroe Township

Leon RosenbergCherry Hill$6.4M
Steven GlassClementon$3.9M
Judith JosephPaterson$3.8M
Jeffrey ApterPrinceton$1.7M
Roberta BallCherry Hill$741K
Marc CantillonLivingston$524K
Sanjay VarmaPrinceton$479K
Manuel SanchezNewark$474K
Robert BransfieldRed Bank$415K
Erika ConcepcionLong Branch$354K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →